Picture Demy-Colton BioFuture 2023 NYC Hand 650x100px

Document › Details

Bruker Corporation. (2/27/17). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.

	Region	Boston, MA
	Country	United States (USA)
	Organisation	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Organisation 2	Cowen & Company LLC
	Group	Cowen (Group)
	Product	Cowen & Co. Annual Health Care Conference 2017 Boston
	Product 2	Barclays Global Healthcare Conference 2017 Miami
	Index term	Bruker–Cowen: investor conference, 201703 supply service Bruker presents at Cowen & Co Annual Health Care Conference 2017
	Index term 2	Bruker–Barclays: investor conference, 201703 supply service Bruker presents at Barclays Global Healthcare Conference
	Person	Mattacchione, Anthony L. (Tony) (Albany Molecular 201804– before Bruker Corp CFO + EMD Millipore)
	Person 2	Laukien, Frank H. (Bruker 201204 President + CEO)

Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:

Cowen and Company 37th Annual Health Care Conference
Monday, March 6, 2017, at 1:20 p.m. Eastern Time
Boston Marriott Copley Place, Boston, MA
Tony Mattacchione, Senior Vice President and Chief Financial Officer

Barclays Global Healthcare Conference
Wednesday, March 15, 2017, at 9:30 a.m. Eastern Time
Loews Miami Beach Hotel, Miami Beach, FL
Frank Laukien, President and Chief Executive Officer

A live audio webcast of both presentations will be available on the Investor section of the Company's website at http://ir.bruker.com. Replays of the presentations will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentations.

About Bruker Corporation

For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: http://www.bruker.com.

Contact:

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

Record changed: 2023-06-05